• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硅纳米线阵列通过诱导乳腺癌干细胞分化来克服化疗耐药性。

Silicon nanowire array overcomes chemotherapeutic resistance by inducing the differentiation of breast cancer stem cells.

机构信息

College of Chemistry & Materials Science, Key Laboratory of Medicinal Chemistry and Molecular Diagnosis of the Ministry of Education, Chemical Biology Key Laboratory of Hebei Province, Hebei University, Baoding, People's Republic of China.

Cheng'an County Hospital of Traditional Chinese Medicine, Handan, People's Republic of China.

出版信息

J Biomed Mater Res B Appl Biomater. 2023 Aug;111(8):1499-1510. doi: 10.1002/jbm.b.35249. Epub 2023 Mar 16.

DOI:10.1002/jbm.b.35249
PMID:36929288
Abstract

Currently, traditional cancer treatment strategies are greatly challenged by the existence of cancer stem cells (CSCs), which are root cause of chemotherapy resistance. Differentiation therapy presents a novel therapeutic strategy for CSC-targeted therapy. However, there are very few studies on the induction of CSCs differentiation so far. Silicon nanowire array (SiNWA) with many unique properties is considered to be an excellent material for various applications ranging from biotechnology to biomedical applications. In this study, we report the SiNWA differentiates MCF-7-derived breast CSCs (BCSCs) into non-CSCs by modulating the morphology of cells. In vitro, the differentiated BCSCs lose the stemness properties and thus become sensitive to chemotherapeutic drugs, eventually leading to the death of BCSCs. Therefore, this work suggests a potential approach for overcoming chemotherapeutic resistance.

摘要

目前,癌症干细胞(CSC)的存在极大地挑战了传统癌症治疗策略,因为 CSC 是化疗耐药性的根源。分化治疗为 CSC 靶向治疗提供了一种新的治疗策略。然而,目前关于 CSC 诱导分化的研究非常少。硅纳米线阵列(SiNWA)具有许多独特的性质,被认为是一种极好的材料,可应用于从生物技术到生物医学应用等各种领域。在这项研究中,我们报告了 SiNWA 通过调节细胞形态将 MCF-7 衍生的乳腺癌 CSC(BCSC)分化为非 CSC。在体外,分化后的 BCSC 失去了干性特征,因此对化疗药物敏感,最终导致 BCSC 死亡。因此,这项工作为克服化疗耐药性提供了一种潜在的方法。

相似文献

1
Silicon nanowire array overcomes chemotherapeutic resistance by inducing the differentiation of breast cancer stem cells.硅纳米线阵列通过诱导乳腺癌干细胞分化来克服化疗耐药性。
J Biomed Mater Res B Appl Biomater. 2023 Aug;111(8):1499-1510. doi: 10.1002/jbm.b.35249. Epub 2023 Mar 16.
2
Basal/HER2 breast carcinomas: integrating molecular taxonomy with cancer stem cell dynamics to predict primary resistance to trastuzumab (Herceptin).基底型/HER2 型乳腺癌:整合分子分类与癌症干细胞动力学,预测曲妥珠单抗(赫赛汀)原发性耐药。
Cell Cycle. 2013 Jan 15;12(2):225-45. doi: 10.4161/cc.23274. Epub 2012 Jan 15.
3
Breast cancer stem cells, heterogeneity, targeting therapies and therapeutic implications.乳腺癌干细胞、异质性、靶向治疗及治疗意义。
Pharmacol Res. 2021 Jan;163:105320. doi: 10.1016/j.phrs.2020.105320. Epub 2020 Dec 1.
4
Induction of immunogenic cell death in radiation-resistant breast cancer stem cells by repurposing anti-alcoholism drug disulfiram.通过重新利用抗酒精药物双硫仑诱导辐射抗性乳腺癌干细胞发生免疫原性细胞死亡。
Cell Commun Signal. 2020 Mar 5;18(1):36. doi: 10.1186/s12964-019-0507-3.
5
A novel lncRNA ROPM-mediated lipid metabolism governs breast cancer stem cell properties.一种新型长链非编码 RNA ROPM 通过脂质代谢调控乳腺癌干细胞特性。
J Hematol Oncol. 2021 Oct 29;14(1):178. doi: 10.1186/s13045-021-01194-z.
6
Selective mode of action of plumbagin through BRCA1 deficient breast cancer stem cells.通过BRCA1缺陷型乳腺癌干细胞的白花丹醌选择性作用模式。
BMC Cancer. 2016 May 26;16:336. doi: 10.1186/s12885-016-2372-4.
7
Disulfiram modulates ROS accumulation and overcomes synergistically cisplatin resistance in breast cancer cell lines.双硫仑调节活性氧积累并协同克服乳腺癌细胞系的顺铂耐药性。
Biomed Pharmacother. 2019 May;113:108727. doi: 10.1016/j.biopha.2019.108727. Epub 2019 Mar 12.
8
Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy.敲低 CD44 对乳腺癌干细胞的分化作用:有前景的分化治疗。
J Transl Med. 2011 Dec 7;9:209. doi: 10.1186/1479-5876-9-209.
9
Do Different Stemness Markers Identify Different Pools of Cancer Stem Cells in Malignancies: A Study on ER+ and ER-Breast Cancer Cell Lines.不同的干性标志物是否能识别不同恶性肿瘤中的癌症干细胞池:对 ER+和 ER-乳腺癌细胞系的研究。
Pathol Oncol Res. 2020 Jan;26(1):371-378. doi: 10.1007/s12253-018-0503-8. Epub 2018 Oct 25.
10
Novel dendritic polyglycerol-conjugated, mesoporous silica-based targeting nanocarriers for co-delivery of doxorubicin and tariquidar to overcome multidrug resistance in breast cancer stem cells.新型树枝状聚甘油偶联介孔硅靶向纳米载体共载多柔比星和塔瑞奎林用于克服乳腺癌干细胞多药耐药
J Control Release. 2021 Feb 10;330:1106-1117. doi: 10.1016/j.jconrel.2020.11.015. Epub 2020 Nov 12.

引用本文的文献

1
Isolation of tumor stem-like cells from primary laryngeal squamous cell carcinoma cells (FD-LS-6).从原发性喉鳞状细胞癌细胞(FD-LS-6)中分离肿瘤干细胞样细胞。
Hum Cell. 2024 Jan;37(1):323-336. doi: 10.1007/s13577-023-00984-6. Epub 2023 Sep 27.